| 39.14 1.5 (3.99%) | 10-15 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 48.34 |
1-year : | 56.47 |
| Resists | First : | 41.39 |
Second : | 48.34 |
| Pivot price | 38.26 |
|||
| Supports | First : | 37.94 |
Second : | 35.81 |
| MAs | MA(5) : | 37.38 |
MA(20) : | 38.47 |
| MA(100) : | 31.42 |
MA(250) : | 25.83 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.4  |
| %K %D | K(14,3) : | 35.6 |
D(3) : | 21.9 |
| RSI | RSI(14): 57.5 |
|||
| 52-week | High : | 41.56 | Low : | 16.15 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PAHC ] has closed below upper band by 32.6%. Bollinger Bands are 12.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 39.25 - 39.4 | 39.4 - 39.55 |
| Low: | 37.08 - 37.26 | 37.26 - 37.44 |
| Close: | 38.85 - 39.13 | 39.13 - 39.4 |
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
Sat, 11 Oct 2025
Revisiting Phibro Animal Health (PAHC) Valuation Following Recent Share Price Swings - Yahoo Finance
Thu, 09 Oct 2025
Phibro Animal Health licenses novel canine periodontal therapy - Investing.com
Wed, 08 Oct 2025
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Wed, 08 Oct 2025
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term - Nasdaq
Wed, 01 Oct 2025
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 0 (M) |
| Shares Float | 20 (M) |
| Held by Insiders | 2.021e+007 (%) |
| Held by Institutions | 0.7 (%) |
| Shares Short | 931 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 1.19 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 190.5 |
| Profit Margin | 3.7 % |
| Operating Margin | 10 % |
| Return on Assets (ttm) | 7.1 % |
| Return on Equity (ttm) | 17.7 % |
| Qtrly Rev. Growth | 38.5 % |
| Gross Profit (p.s.) | 4.94659e+008 |
| Sales Per Share | 1.58537e+009 |
| EBITDA (p.s.) | 2.16768e+008 |
| Qtrly Earnings Growth | 2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 80 (M) |
| PE Ratio | 32.89 |
| PEG Ratio | 0 |
| Price to Book value | 0.2 |
| Price to Sales | 0 |
| Price to Cash Flow | 4.55 |
| Dividend | 0 |
| Forward Dividend | 873350 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|